Healthcare provider profile · identity verified

Amadeo D. Rivera, M.D.

Internal Medicine · REDLANDS, CA · NPI 1205063534

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	562	192
Amlodipine Besylate	Amlodipine Besylate	418	159
Losartan Potassium	Losartan Potassium	362	125
Levothyroxine Sodium	Levothyroxine Sodium	263	78
Lisinopril	Lisinopril	197	74
Pantoprazole Sodium	Pantoprazole Sodium	147	40
Gabapentin	Gabapentin	138	48
Tamsulosin Hcl	Tamsulosin Hcl	133	42
Fluticasone Propionate	Fluticasone Propionate	132	49
Albuterol Sulfate Hfa	Albuterol Sulfate	131	77
Metoprolol Tartrate	Metoprolol Tartrate	128	47
Famotidine	Famotidine	121	55
Simvastatin	Simvastatin	120	44
Hydrochlorothiazide	Hydrochlorothiazide	119	46
Furosemide	Furosemide	118	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	111	21
Metformin Hcl	Metformin Hcl	107	43
Metoprolol Succinate	Metoprolol Succinate	101	36
Alendronate Sodium	Alendronate Sodium	96	37
Trazodone Hcl	Trazodone Hcl	96	32
Omeprazole	Omeprazole	92	34
Allopurinol	Allopurinol	82	38
Atenolol	Atenolol	74	26
Hydralazine Hcl	Hydralazine Hcl	73	31
Potassium Chloride	Potassium Chloride	68	26
Ibuprofen	Ibuprofen	67	38
Glipizide	Glipizide	65	27
Hydrocortisone	Hydrocortisone	65	32
Metformin Hcl Er	Metformin Hcl	62	25
Rosuvastatin Calcium	Rosuvastatin Calcium	60	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	21
Azelastine Hcl	Azelastine Hcl	50	19
Pregabalin	Pregabalin	49	suppressed
Sertraline Hcl	Sertraline Hcl	46	15
Pradaxa	Dabigatran Etexilate Mesylate	45	15
Sumatriptan Succinate	Sumatriptan Succinate	45	11
Tizanidine Hcl	Tizanidine Hcl	45	12
Cefadroxil	Cefadroxil	44	35
Terazosin Hcl	Terazosin Hcl	42	17
Triamcinolone Acetonide	Triamcinolone Acetonide	42	28
Pravastatin Sodium	Pravastatin Sodium	41	14
Carvedilol	Carvedilol	40	18
Lovastatin	Lovastatin	40	16
Jardiance	Empagliflozin	38	16
Meloxicam	Meloxicam	35	12
Venlafaxine Hcl Er	Venlafaxine Hcl	35	12
Colchicine	Colchicine	34	17
Escitalopram Oxalate	Escitalopram Oxalate	34	11
Fluoxetine Hcl	Fluoxetine Hcl	34	12
Breyna	Budesonide/Formoterol Fumarate	33	suppressed
Naproxen	Naproxen	32	16
Mirtazapine	Mirtazapine	31	14
Ondansetron Odt	Ondansetron	31	11
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Tramadol Hcl	Tramadol Hcl	31	suppressed
Alvesco	Ciclesonide	30	13
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Donepezil Hcl	Donepezil Hcl	29	14
Doxycycline Monohydrate	Doxycycline Monohydrate	29	28
Humulin N	Insulin Nph Human Isophane	29	11
Levetiracetam	Levetiracetam	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	13
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Lactulose	Lactulose	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Montelukast Sodium	Montelukast Sodium	25	12
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	20
Propranolol Hcl	Propranolol Hcl	24	12
Finasteride	Finasteride	23	11
Olanzapine	Olanzapine	23	suppressed
Baclofen	Baclofen	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Prednisone	Prednisone	21	15
Venlafaxine Hcl	Venlafaxine Hcl	21	suppressed
Nystatin	Nystatin	20	12
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Eliquis	Apixaban	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Humulin R	Insulin Regular, Human	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	18
Clonidine Hcl	Clonidine Hcl	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Fluocinonide	Fluocinonide	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Amantadine	Amantadine Hcl	14	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Calcitriol	Calcitriol	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	12	12
Ciclopirox	Ciclopirox	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Trospium Chloride	Trospium Chloride	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Motegrity	Prucalopride Succinate	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error